Cardiopulmonary Bypass-Induced Lymphocytopenia and the Potential Effects of Protease Inhibitor
Status:
Terminated
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
In previous studies, 90% of patients who underwent elective cardiopulmonary bypass procedure
manifested CD4 counts of less than 500 cells/microliter in the immediate (day 1)
post-operative period. This study will investigate whether or not Nelfinavir increases those
CD4 counts in the post-operative period.
Phase:
Phase 1
Details
Lead Sponsor:
Mayo Clinic
Treatments:
HIV Protease Inhibitors Nelfinavir Protease Inhibitors